Keywords: بازدارنده فسفودی استراز 5; Erectile dysfunction drug; Non-arteritic anterior ischemic optic neuropathy; Phosphodiesterase 5 inhibitor; Pfizer; Sildenafil; Tadalafil; Vardenafil;
مقالات ISI بازدارنده فسفودی استراز 5 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بازدارنده فسفودی استراز 5; Adipocyte; Adipogenesis; Nitric oxide; Phosphodiesterase 5; Phosphodiesterase 5 inhibitor; White adipose tissue;
Increased motor neuron resilience by small molecule compounds that regulate IGF-II expression
Keywords: بازدارنده فسفودی استراز 5; ALS; amyotrophic lateral sclerosis; ChAT; choline acetyltransferase; FTD; frontotemporal dementia; IGF-II; insulin-like growth factor II; IGF-IIR; IGF-II/cation-independent mannose-6-phosphate receptor; IGF-IR; IGF-I receptor; isl-1/2; islet 1 and 2; iPSC
Riociguat for patients with chronic thromboembolic pulmonary hypertension: Usefulness of transitioning from phosphodiesterase type 5 inhibitor
Keywords: بازدارنده فسفودی استراز 5; Chronic thromboembolic pulmonary hypertension; Soluble guanylate cyclase stimulator; Phosphodiesterase 5 inhibitor; Mean pulmonary arterial pressure;
Clinical and hemodynamic improvements after adding ambrisentan to background PDE5i therapy in patients with pulmonary arterial hypertension exhibiting a suboptimal therapeutic response (ATHENA-1)
Keywords: بازدارنده فسفودی استراز 5; Ambrisentan; Endothelin A receptor antagonist; Pulmonary Hypertension; Phosphodiesterase 5 inhibitor; Combination drug therapy; Outcome assessment;
Phosphodiesterase 5 inhibition as a therapeutic target for ischemic stroke: A systematic review of preclinical studies
Keywords: بازدارنده فسفودی استراز 5; Akt; protein kinase B; Bax; bcl-2-like protein 4; BCCAO; bilateral common carotid artery occlusion; Bcl-xL; B-cell lymphoma-extra large; bcl-2; B-cell lymphoma 2; MAPK; mitogen-activated protein kinase; MCAO; middle cerebral artery occlusion; PDE5i; phosp
Calcilytics enhance sildenafil-induced antiproliferation in idiopathic pulmonary arterial hypertension
Keywords: بازدارنده فسفودی استراز 5; Pulmonary hypertension; Calcium-sensing receptor; Calcilytic; Phosphodiesterase 5 inhibitor; NPS2143; Sildenafil
Doit on proposer une rééducation érectile après prostatectomie radicale ? Revue de la littérature du CAMS de l’AFU
Keywords: بازدارنده فسفودی استراز 5; Réhabilitation précoce; Prostatectomie radicale; Injection intra-caverneuse; Inhibiteur de la phosphodiestérase de type 5Therapy erectile dysfunction; Radical prostatectomy; Penile rehabilitation; Phosphodiesterase 5 inhibitor; Intracavernous injection
Effectiveness of Tadalafil 5âmg Once Daily in the Treatment of Men with Lower Urinary Tract Symptoms Suggestive to Benign Prostatic Hyperplasia With or Without Erectile Dysfunction: Results from Naturalistic Observational TadaLutsEd Study
Keywords: بازدارنده فسفودی استراز 5; Benign Prostatic Hyperplasia; Erectile Dysfunction; Lower Urinary Tract Symptoms; Phosphodiesterase 5 Inhibitor; Tadalafil; IIEF; IPSS;
Genetics of Erectile Dysfunction
Keywords: بازدارنده فسفودی استراز 5; penis; erectile dysfunction; genetics; genome; ethnology; ACE; angiotensin converting enzyme; Ang; angiotensin; CSMC; cavernous smooth muscle cell; D; deletion; ED; erectile dysfunction; eNOS; endothelial NOS; GWAS; genome wide association study; Hcy; hom
Resveratrol Stimulates Hydrogen Sulfide (H2S) Formation to Relax Murine Corpus Cavernosum
Keywords: بازدارنده فسفودی استراز 5; Corpus Cavernosum; Resveratrol; Phosphodiesterase 5 Inhibitor; Hydrogen Sulfide; Erectile Dysfunction
Enantioselective total synthesis of pyrroloquinolone as a potent PDE5 inhibitor
Keywords: بازدارنده فسفودی استراز 5; Phosphodiesterase 5 inhibitor; Pyrroloquinolone; Enantioselective synthesis; Chiral auxiliaries; Noyori hydrogenation;
ORIGINAL RESEARCH-ED PHARMACOTHERAPY: The Efficacy and Safety of Udenafil [Zydena] for the Treatment of Erectile Dysfunction in Hypertensive Men Taking Concomitant Antihypertensive Agents
Keywords: بازدارنده فسفودی استراز 5; Erectile Dysfunction; Phosphodiesterase 5 Inhibitor; Udenafil; Hypertension;
Possible involvement of l-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride
Keywords: بازدارنده فسفودی استراز 5; Berberine; Cyclic GMP; Depression; Forced-swim test; Neurotransmitters; Tail-suspension test; l-arginine; Nitric oxide; Phosphodiesterase 5 inhibitor
Immunohistochemical Distribution of Cyclic GMP-Dependent Protein Kinase-1 in Human Prostate Tissue
Keywords: بازدارنده فسفودی استراز 5; Benign prostatic hyperplasia; Cyclic nucleotides; Lower urinary tract symptoms; Phosphodiesterase 5; Phosphodiesterase 5 inhibitor; Protein kinase G
Microarray analysis of gene expression profile in the corpus cavernosum of hypercholesterolemic rats after chronic treatment with PDE5 inhibitor
Keywords: بازدارنده فسفودی استراز 5; Hypercholesterolemia; Erectile dysfunction; cDNA microarray; Phosphodiesterase 5 inhibitor; Gene expression
A chemometric study of phosphodiesterase 5 inhibitors
Keywords: بازدارنده فسفودی استراز 5; Phosphodiesterase 5 inhibitor; Chemometric; HCA
Safety and Efficacy of Vardenafil, a Selective Phosphodiesterase 5 Inhibitor, in Patients with Erectile Dysfunction and Arterial Hypertension Treated with Multiple Antihypertensives
Keywords: بازدارنده فسفودی استراز 5; Erectile Dysfunction; Phosphodiesterase 5 Inhibitor; Vardenafil; Hypertension;